{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:57:29Z","timestamp":1790125049329,"version":"4.0.1"},"reference-count":33,"publisher":"Impact Journals, LLC","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,9]]},"DOI":"10.18632\/oncotarget.10102","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T09:14:41Z","timestamp":1466068481000},"page":"51720-51732","source":"Crossref","is-referenced-by-count":53,"title":["Protocadherin 17 functions as a tumor suppressor suppressing Wnt\/\u03b2-catenin signaling and cell metastasis and is frequently methylated in breast cancer"],"prefix":"10.18632","volume":"7","author":[{"given":"Xuedong","family":"Yin","sequence":"first","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingxiu","family":"Xiang","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Mu","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Mao","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong and CUHK Shenzhen Research Institute, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Li","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong and CUHK Shenzhen Research Institute, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong and CUHK Shenzhen Research Institute, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Li","sequence":"additional","affiliation":[{"name":"Oncology Department, Suining Sichuan Center Hospital, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Feng","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Luo","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"Wei","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Peng","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Ren","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Tao","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"},{"name":"Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong and CUHK Shenzhen Research Institute, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Jemal","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5732\/cjc.012.10300","article-title":"Aberrant promoter CpG methylation and its translational applications in breast cancer","volume":"32","author":"Tao","year":"2013","journal-title":"Chin J Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4161\/epi.3.3.6387","article-title":"Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors","volume":"3","author":"Carvallo","year":"2008","journal-title":"Epigenetics"},{"key":"4","first-page":"3105","article-title":"Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21. 3 locus, occurs in a large percentage of human breast cancers","volume":"61","author":"Pfeifer","year":"2001","journal-title":"Cancer Res"},{"key":"5","first-page":"4346","article-title":"Aberrant methylation of the estrogen receptor and E-cadherin 5\u2032 CpG islands increases with malignant progression in human breast cancer","volume":"60","author":"Graff","year":"2000","journal-title":"Cancer Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"e110990","DOI":"10.1371\/journal.pone.0110990","article-title":"Zinc-Finger Protein 545 Inhibits Cell Proliferation as a Tumor Suppressor through Inducing Apoptosis and is Disrupted by Promoter Methylation in Breast Cancer","volume":"9","author":"Tao","year":"2014","journal-title":"PLoS One"},{"key":"7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4161\/cbt.10.5.12726","article-title":"PLCD1 is a functional tumor suppressor inducing G(2)\/M arrest and frequently methylated in breast cancer","volume":"10","author":"Ren","year":"2010","journal-title":"Cancer biology & therapy"},{"key":"8","doi-asserted-by":"crossref","first-page":"e29783","DOI":"10.1371\/journal.pone.0029783","article-title":"The Ubiquitin Peptidase UCHL1 Induces G0\/G1 Cell Cycle Arrest and Apoptosis Through Stabilizing p53 and Is Frequently Silenced in Breast Cancer","volume":"7","author":"Tao","year":"2012","journal-title":"PLoS One"},{"key":"9","article-title":"Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt\/beta-catenin signalling and apoptosis regulation in breast cancer cells","author":"Tao","year":"2013","journal-title":"J Cell Mol Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/bcr3399","article-title":"DACT1, an antagonist to Wnt\/beta-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer","volume":"15","author":"Tao","year":"2013","journal-title":"BCR"},{"key":"11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/hmg\/8.3.459","article-title":"Methylation profiling of CpG islands in human breast cancer cells","volume":"8","author":"Laux","year":"1999","journal-title":"Hum Mol Genet"},{"key":"12","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1038\/sj.onc.1205597","article-title":"DNA methylation and breast carcinogenesis","volume":"21","author":"Jones","year":"2002","journal-title":"Oncogene"},{"key":"13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2217\/fon.09.89","article-title":"DNA methylation as a biomarker in breast cancer","volume":"5","author":"Harbeck","year":"2009","journal-title":"Future Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/epi.14.20","article-title":"DNA methylation markers for early detection of women's cancer: promise and challenges","volume":"6","author":"Widschwendter","year":"2014","journal-title":"Epigenomics"},{"key":"15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/carcin\/bgq053","article-title":"Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma","volume":"31","author":"Inazawa","year":"2010","journal-title":"Carcinogenesis"},{"key":"16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/path.4093","article-title":"Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers","volume":"229","author":"He","year":"2013","journal-title":"J Pathol"},{"key":"17","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.12659\/MSM.895603","article-title":"Protocadherin17 Promoter Methylation is a Potential Predictive Biomarker in Clear Cell Renal Cell Carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Med Sci Monit"},{"key":"18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10038-007-0151-4","article-title":"Retinoblastoma and mental retardation microdeletion syndrome: clinical characterization and molecular dissection using array CGH","volume":"52","author":"Mari","year":"2007","journal-title":"J Hum Genet"},{"key":"19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.gep.2009.07.006","article-title":"Expression of protocadherin-9 and protocadherin-17 in the nervous system of the embryonic zebrafish","volume":"9","author":"Murakami","year":"2009","journal-title":"Gene Expr Patterns"},{"key":"20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuron.2013.03.031","article-title":"Protocadherin 17 regulates presynaptic assembly in topographic corticobasal Ganglia circuits","volume":"78","author":"Nakazawa","year":"2013","journal-title":"Neuron"},{"key":"21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/sj.onc.1209154","article-title":"Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation","volume":"25","author":"Tao","year":"2006","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1038\/onc.2008.101","article-title":"PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer","volume":"27","author":"Parsons","year":"2008","journal-title":"Oncogene"},{"key":"23","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1158\/0008-5472.CAN-05-4437","article-title":"Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers","volume":"66","author":"Inazawa","year":"2006","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/jvh.12265","article-title":"PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt\/beta-catenin signalling pathway in hepatocellular carcinoma","volume":"22","author":"Lu","year":"2015","journal-title":"J Viral Hepat"},{"key":"25","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1158\/0008-5472.CAN-14-0427","article-title":"A Novel Wnt Regulatory Axis in Endometrioid Endometrial Cancer","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Research"},{"key":"26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/cam.5.2.14374","article-title":"Non-clustered protocadherin","volume":"5","author":"Kim","year":"2011","journal-title":"Cell Adh Migr"},{"key":"27","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/jcb.25135","article-title":"Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma","volume":"116","author":"Hu","year":"2015","journal-title":"Journal of cellular biochemistry"},{"key":"28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"29","doi-asserted-by":"crossref","first-page":"2087204","DOI":"10.1155\/2016\/2087204","article-title":"The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer","volume":"2016","author":"Wilson","year":"2016","journal-title":"Stem Cells Int"},{"key":"30","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1158\/0008-5472.CAN-08-3694","article-title":"CMTM3, located at the critical tumor suppressor locus 16q22. 1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis","volume":"69","author":"Yu","year":"2009","journal-title":"Cancer Res"},{"key":"31","first-page":"1635","article-title":"OPCML is frequently methylated in human colorectal cancer and its restored expression reverses EMT via downregulation of smad signaling","volume":"5","author":"Xiang","year":"2015","journal-title":"Am J Cancer Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0002-9440(10)65157-7","article-title":"Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis","volume":"155","author":"Ambinder","year":"1999","journal-title":"Am J Pathol"},{"key":"33","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/hmg\/11.18.2091","article-title":"Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells","volume":"11","author":"Robertson","year":"2002","journal-title":"Hum Mol Genet"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:56:59Z","timestamp":1748973419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":33,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2016,8,9]]}},"alternative-id":["10102","27351130"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10102","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]}}}